Anglican: Cefaclor granules obtained drug registration certificate

Announcement from Anglijian Company: Recently, the company has received the "Drug Registration Certificate" for Cefradine Granules issued by the National Medical Products Administration. Cefradine Granules are suitable for bacterial infectious diseases caused by streptococci, pneumoniae, gonococci, Klebsiella pneumoniae, Escherichia coli, Citrobacter, Serratia, Proteus, and Haemophilus influenzae sensitive to cefradine, including acute bronchitis, pneumonia, secondary infections of chronic respiratory system infections, cystitis, pyelonephritis, gonorrheal urethritis, cholecystitis, cholangitis, otitis media, sinusitis, and scarlet fever.